Capnography During ERCP (EndoBreath)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01072474
Recruitment Status : Completed
First Posted : February 22, 2010
Last Update Posted : August 24, 2012
Information provided by:
Technische Universität München

Brief Summary:
In the study the value of capnography for avoiding complications during sedation for ERCP is evaluated.

Condition or disease Intervention/treatment Phase
Hypoxemia Complications Procedure: Capnography Procedure: Standard monitoring Phase 3

Detailed Description:
In this randomized controlled trial the utility of capnography gets evaluated. Hypoxemia may occur during sedation with midazolam and propofol. Whether hypoxemia may be prevented by an additional capnographic monitoring is subject of the study.

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 242 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Prevention
Official Title: Capnography as an Adjunct to Standard Monitoring During Midazolam and Propofol Sedation for ERCP
Study Start Date : February 2010
Actual Primary Completion Date : February 2011
Actual Study Completion Date : March 2012

Arm Intervention/treatment
Experimental: Capnography
Arm with capnographic monitoring
Procedure: Capnography
Capnographic monitoring

Placebo Comparator: Standard
Standard monitoring.
Procedure: Standard monitoring
Standard monitoring

Primary Outcome Measures :
  1. Hypoxemia [ Time Frame: From the beginning to the end of the ERCP procedure, i.e. from 0h to approximately 2h ]

Secondary Outcome Measures :
  1. Further complications [ Time Frame: From the beginning to the end of the ERCP procedure, i.e. from 0h to approximately 2h ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Age>=18
  • Scheduled for colonoscopy with midazolam and propofol sedation

Exclusion Criteria:

  • No informed consent
  • ASA V
  • Pregnancy
  • Prexisting hypotension, bradycardia or hypoxemia

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01072474

Technische Universität München
Munich, Bavaria, Germany, 81675
Knappschaftskrankenhaus der Ruhr-Universität Bochum
Bochum, Germany, 44892
Deutsche Klinik für Diagnostik
Wiesbaden, Germany, 65191
Sponsors and Collaborators
Technische Universität München
Principal Investigator: Stefan von Delius, MD Technische Universität München

Additional Information:
Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Stefan von Delius, II. Medizinische Klinik der Technischen Universität München Identifier: NCT01072474     History of Changes
Other Study ID Numbers: 2680/10
First Posted: February 22, 2010    Key Record Dates
Last Update Posted: August 24, 2012
Last Verified: August 2012

Keywords provided by Technische Universität München:
Gastrointestinal endoscopy

Additional relevant MeSH terms:
Signs and Symptoms, Respiratory
Signs and Symptoms